High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 8, 2007, Pages 1047-1053

  Salmhofer, Wolfgang ^a   Hermann, J ^a   Joch, M ^a   Kerl, H ^a   Graninger, W ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anti RNP 70 antibodies; Anti Sm antibodies; Anti U1 snRNP antibodies; Antibody levels; Mixed connective tissue disease; Systemic lupus erythematosus

Indexed keywords

ANTIGEN; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; RIBONUCLEOPROTEIN ANTIBODY; RNP 70 ANTIBODY; RNP A ANTIBODY; RNP C ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMBB ANTIBODY; SMD ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REFERENCE VALUE; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AUTOANTIGENS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; RECOMBINANT PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; SENSITIVITY AND SPECIFICITY;

EID: 34548189268     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02163.x     Document Type: Article

References (27)

1. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
2. von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-358.
3. Burdt MA, Hofmann RW, Deutscher SL et al. Long-term outcome in mixed connective tissue disease. Arthritis Rheum 1999; 42: 899-909.
4. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991; 18: 1511-1519.
5. Lundberg I, Nyman U, Pettersson I, Hedfors E. Clinical manifestations and anti-(U1) snRNP antibodies: A prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 1992; 31: 811-817.
6. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
7. Mahler M, Stinton LM, Fitzler MJ. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of a SmD3 peptide-based immunoassay. Clin Diagn Lab Immunol 2005; 12: 107-113.
8. Brahms H, Raker VA, van Venrooij J, Lührmann R. A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states. Arthritis Rheum 1997; 40: 672-682.
9. Hoch SO. The Sm antigens, p. B2.4/1-B2.4/29. In: RN Maini, WJ van Venrooji., eds. Manual of Biological Markers of Disease. Kluwer Academic, Dordrecht, The Netherlands.
10. Ghirardello A, Doria A, Vesco P et al. Blotting patterns of IgG anti-(U1) RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996; 16: 145 -150.
11. Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 1984; 259: 5907-5914.
12. Yamamoto AM, Amoura Z, Johannet C et al. Quantiative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue disease. Arthritis Rheum 2000; 43: 689-698.
13. Migliorini P, Baldini C, Rocci V, Bomabrdieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity 2005; 38: 47-54.
14. Wenzel J, Gerdsen R, Uerlich M et al. Antibodies targeting extractable nuclear antigens: Historical development and current knowledge. Br J Dermatol 2001; 145: 859-867.
15. Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 311-335.
16. Hoffman RW, Sharp GC, Deutscher SL. Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease. Arthritis Rheum 1995; 38: 1837-1844.
17. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328-334.
18. Sharp GC, Irwin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-159.
19. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
20. Tan EM, Smolen JS, McDougal JS et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 2002; 29: 68-74.
21. Bizzaro N, Tozzoli R, Tonutti E et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: A collaborative study with the biomedical industry. J Immunol Methods 1998; 219: 99-107.
22. St Clair EW, Query CC, Bentley R et al. Expression of autoantibodies of recombinant (u1) RNP-associated 70K antigen in systemic lupus erythematosus. Clin Immunol Immunopathol 1990; 54: 266-280.
23. Arnett FC, Hamilton RG, Roebber MG, Herley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773-1776.
24. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 918-923.
25. Combe B, Rucheton M, Graafland H et al. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 1989; 75: 18-24.
26. Ihn H, Yamane K, Yazawa N et al. Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis. Clin Exp Immunol 1999; 117: 383-387.
27. Gaubitz M, Wegmann C, Schotte H, Willeke P, Domschke W. Differentiation of RNP- and Sm-Antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens. Cell Mol Biol 2002; 48: 317-332.